These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

295 related items for PubMed ID: 17848356

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. [Cardiovascular prevention: not necessary under the age of 40].
    Walma EP.
    Ned Tijdschr Geneeskd; 2009; 153():B351. PubMed ID: 19785804
    [Abstract] [Full Text] [Related]

  • 3. Cardiovascular protection paradigms: is change on the horizon?
    Papademetriou V.
    Rev Cardiovasc Med; 2007; 8(4):200-13. PubMed ID: 18192943
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Blood pressure and antihypertensive therapy according to the global cardiovascular risk level in Italy: the CHECK Study.
    Filippi A, Casula M, Tragni E, Brignoli O, Cricelli C, Poli A, Catapano AL, CHECK Study Group.
    Eur J Cardiovasc Prev Rehabil; 2010 Oct; 17(5):562-8. PubMed ID: 20308908
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Intermittent claudication: a plea for guidelines for medical management.
    Powell JT.
    Eur J Vasc Endovasc Surg; 2007 Apr; 33(4):451-2. PubMed ID: 17196850
    [No Abstract] [Full Text] [Related]

  • 13. Rational prescribing in primary care (RaPP): a cluster randomized trial of a tailored intervention.
    Fretheim A, Oxman AD, Håvelsrud K, Treweek S, Kristoffersen DT, Bjørndal A.
    PLoS Med; 2006 Jun; 3(6):e134. PubMed ID: 16737346
    [Abstract] [Full Text] [Related]

  • 14. Cholesterol goal attainment in hypertensive patients: the impact of metabolic syndrome components.
    Rodrigues CJ, Ribeiro HF, Ribeiro AB, Zanella MT, Batista MC.
    Metab Syndr Relat Disord; 2012 Jun; 10(3):195-201. PubMed ID: 22313142
    [Abstract] [Full Text] [Related]

  • 15. Optimizing diabetes care regarding cardiovascular targets at general practice level: Direct@GP.
    Wens J, Gerard R, Vandenberghe H.
    Prim Care Diabetes; 2011 Apr; 5(1):19-24. PubMed ID: 21030327
    [Abstract] [Full Text] [Related]

  • 16. [Type 2 diabetes and cardiovascular risk: lessons from therapeutic trials].
    Lièvre M.
    Rev Prat; 2001 Oct 15; 51(16):1793-9. PubMed ID: 11795124
    [Abstract] [Full Text] [Related]

  • 17. [Monitoring drug adherence for hypertensive and dyslipidemic patients in networks of community-based pharmacists and physicians].
    Santschi V, Rodondi N, Bugnon O, Pannatier A, Burnier M.
    Rev Med Suisse; 2008 Sep 10; 4(170):1928, 1930-2, 1934 passim. PubMed ID: 18847122
    [Abstract] [Full Text] [Related]

  • 18. New cholesterol guidelines emphasize risk assessment.
    Grundy SM.
    Am J Manag Care; 2002 Jan 10; Suppl():1, 3. PubMed ID: 11833450
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Management of risk factors among ambulatory patients at high cardiovascular risk in Canada: a follow-up study.
    Elbarasi EA, Goodman SG, Yan RT, Tan MK, Hackam DG, Leiter LA, Langer A, Yan AT, Guidelines Oriented Approach in Lipid Lowering (GOALL) Registry and Vascular Protection (VP) Registry Investigators.
    Can J Cardiol; 2013 Dec 10; 29(12):1586-92. PubMed ID: 24041994
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.